Ticker
ORMPCompany Name
ORAMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Income Common Stock | Net Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -24.22M | -1210.9% | $ 2M |
3/31/2025 | $ -28.24M | -1411.9% | $ 2M |
12/31/2024 | $ -19.06M | 0% | $ 0 |
9/30/2024 | $ 4.46M | 0% | $ 0 |
6/30/2024 | $ 20.86M | 0% | $ 0 |
3/31/2024 | $ 10.46M | 1551.34% | $ 674K |
12/31/2023 | $ 5.53M | 412.31% | $ 1.34M |
9/30/2023 | $ -15.34M | -759.23% | $ 2.02M |
6/30/2023 | $ -19.38M | -716.8% | $ 2.7M |
3/31/2023 | $ -29.25M | -1082.06% | $ 2.7M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Revenues
(=) Net %
Net % for ORAMED PHARMACEUTICALS INC is calculated as follows: Net Inc. Cmn. [ $ -11.51M ] / Revenues [ $ 2.71M ]
(=) Net % [ -424.76% ]
Minimum
Mar 31, 2025
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.19K |
---|---|
min | -63.83% |
max | 69.74% |
average | 4.8% |
median | 5.26% |
std | 19.81% |